Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRC | Q99895 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | TYMP | P19971 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.32 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6413165 | 0.98 | CTRC (0.43) | CTRCTYRHTTNPC1HPGD | |
| Ammonia Solution, Strong SCHEMBL995128 | 0.96 | CTRC (0.42) | CTRCTYRHTTNPC1HPGD | |
| Phosphine SCHEMBL20163265 | 0.92 | TYR (0.47) | CTRCTYRHTTCYP3A4TYMP | |
| Phosphine SCHEMBL1535934 | 0.92 | TYR (0.47) | CTRCTYRHTTCYP3A4TYMP | |
| Ammonia Solution, Strong SCHEMBL7027226 | 0.88 | TYR (0.47) | CTRCTYRHTTCYP3A4TYMP | |
| Ammonia Solution, Strong SCHEMBL3782696 | 0.88 | TYR (0.47) | CTRCTYRHTTCYP3A4TYMP | |
| Ammonia Solution, Strong SCHEMBL20163276 | 0.88 | TYR (0.47) | CTRCTYRHTTCYP3A4TYMP | |
| SCHEMBL30044969 | 0.87 | TYR (0.50) | CTRCTYRHTTNPC1HPGD | |
| SCHEMBL4633219 | 0.87 | TYR (0.50) | CTRCTYRHTTNPC1HPGD | |
| SCHEMBL2494501 | 0.80 | PRKCI (0.33) | HPGDTYMP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11859074-B2 | Curable fluoroelastomer composition | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-01-02 | — | — | US | claimed |
| US-20210292533-A1 | CURABLE FLUOROELASTOMER COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY | 2021-09-23 | — | — | US | claimed |
| US-20210189111-A1 | CURABLE FLUOROELASTOMER COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY | 2021-06-24 | — | — | US | claimed |
| EP-3837309-A1 | CURABLE FLUOROELASTOMER COMPOSITION | 3M Innovative Properties Company (US) | 2021-06-23 | — | — | EP | claimed |
| EP-3807355-A1 | CURABLE FLUOROELASTOMER COMPOSITION | 3M Innovative Properties Company (US) | 2021-04-21 | — | — | EP | claimed |
| EP-3775019-A1 | BLENDS OF CROSSLINKING AGENTS FOR FLUOROELASTOMERS | 3M Innovative Properties Company (US) | 2021-02-17 | — | — | EP | claimed |
| EP-3755739-A1 | CURABLE FLUOROELASTOMER COMPOSITION | 3M Innovative Properties Company (US) | 2020-12-30 | — | — | EP | claimed |
| EP-3755745-A1 | BLENDS OF CROSSLINKING AGENTS FOR FLUOROELASTOMERS | 3M Innovative Properties Company (US) | 2020-12-30 | — | — | EP | claimed |
| EP-3755744-A1 | CURABLE FLUOROELASTOMER COMPOSITION | 3M Innovative Properties Company (US) | 2020-12-30 | — | — | EP | claimed |
| US-20200369867-A1 | CURABLE FLUOROELASTOMER COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY | 2020-11-26 | — | — | US | claimed |
| WO-2020035776-A1 | CURABLE FLUOROELASTOMER COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-02-20 | — | — | WO | claimed |
| WO-2019197915-A1 | BLENDS OF CROSSLINKING AGENTS FOR FLUOROELASTOMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-10-17 | — | — | WO | claimed |
| WO-2019159070-A1 | CURABLE FLUOROELASTOMER COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-08-22 | — | — | WO | claimed |
| WO-2019159066-A1 | BLENDS OF CROSSLINKING AGENTS FOR FLUOROELASTOMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-08-22 | — | — | WO | claimed |
| WO-2019159067-A1 | CURABLE FLUOROELASTOMER COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-08-22 | — | — | WO | claimed |
| US-12509569-B2 | Curable fluoropolymer compositions comprising metal fluoride particles and articles therefrom | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-12-30 | — | — | US | disclosed |
| US-12428384-B2 | Hydroxy-functionalized triazine compounds, curable fluoropolymer compositions comprising such compounds and cured articles therefrom | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-09-30 | — | — | US | disclosed |
| EP-0139404-B1 | BIOCIDAL WATER TREATMENT | Albright & Wilson Limited (GB) | 1988-02-03 | — | — | EP | disclosed |
| US-4673509-A | ADDING PHOSPHONIUM COMPOUND | ALBRIGHT & WILSON LIMITED (GB) | 1987-06-16 | — | — | US | disclosed |
| EP-0139404-A1 | Biocidal water treatment | Albright & Wilson Limited (GB) | 1985-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12428384-B2 | Hydroxy-functionalized triazine compounds, curable fluoropolymer compositions comprising such compounds and cured articles therefrom | ALKBH3, HDGF, UHRF1 | CTRC 3071/4885TYR 1508/4885HTT 206/4885 |
| US-12509569-B2 | Curable fluoropolymer compositions comprising metal fluoride particles and articles therefrom | TIAM1, CARM1, NPM1 | CTRC 316/4885TYR 1683/4885HTT 4438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.